Centinel Spine® Hits Another Revenue Record in First Quarter 2024 as prodisc
Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced achievement of record revenue in the first quarter of 2024—outperforming Q4 2023, its previous record quarter.